Personal Finance

Why Diplomat Pharmacy Stock Jumped Today

Hands taking medications from pharmacy shelves

What happened

Shares of Diplomat Pharmacy (NYSE: DPLO) are up 16% as of 12:25 p.m. EDT after the company announced that Brian Griffin will become the new CEO and chairman of the board, effective next month.

So what

The news isn't surprising. Earlier this week, Diplomat said it was focused on an external candidate and that chief financial officer Atul Kavthekar was temporarily taking over as interim CEO for Jeff Park, who will resign as interim CEO, effective tomorrow.

Hands taking medications from pharmacy shelves

Image source: Getty Images.

Brian Griffin is currently CEO of IngenioRx, the pharmacy benefit manager (PBM) of Anthem . Given Diplomat's move into the PBM space with recent acquisitions of National Pharmaceutical Services and LDI Integrated Pharmacy Services, Griffin seems like a good fit to replace Phil Hagerman, who retired in January. Griffin also worked at PBM Express Scripts , and his prior experience at Anthem in its commercial and specialty business division and Empire BlueCross BlueShield health plan could be helpful in negotiations with insurers for the rest of Diplomat's business.

Griffin is being replaced by IngenioRx's chief operating officer, Deepti Jain, so it's in familiar hands.

Now what

With shares well off their lows that followed the announced acquisitions, investors have clearly decided that the move into the PBM business is a good long-term strategy. Now that things in the leadership position have finally settled down, the company can get to work making the transition.

10 stocks we like better than Diplomat Pharmacy

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has quadrupled the market.*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Diplomat Pharmacy wasn't one of them! That's right -- they think these 10 stocks are even better buys.

Click here to learn about these picks!

*Stock Advisor returns as of May 8, 2018

Brian Orelli has no position in any of the stocks mentioned. The Motley Fool recommends Diplomat Pharmacy. The Motley Fool has a disclosure policy .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics


The Motley Fool

Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.

Learn More